Companies · Other Health Care

LoneStar Heart, Inc.

IRVINE · Other Health Care

Diligence memoA one-page analyst read on LoneStar Heart, Inc. — recommendation, valuation, rhythm, risks.
$25.2M
Total raised · real
5
Rounds
4.2×
Latest step-up
Top 14%
Sector rank · raised
Series A
Latest stage · inferred · Mon Mar 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

LoneStar Heart, Inc. looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.70× the median modeled value of Series A Other Health Care companies in 2016–2018 (157 peers) — value vs value, same stage and era.
  • Within the normal band (70% of peer median) for its niche.
Dormant
  • Last raise 9.3 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

LoneStar Heart, Inc. is one of 5377 Other Health Care companies tracked from IRVINE. By capital raised it ranks in the upper tier (ahead of 87% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
5
Investors (latest)
2017-03-13
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$125M$250M$375M$500MSeries A · 2010-06-03 Raised $10M (real) Modeled valuation $205M (est)$10M$205MSeries A2010Series A · 2011-09-30 Raised $7.4M (real) Modeled valuation $150M (est)$7.4M$150MSeries A2011Series A · 2013-11-04 Raised $2.4M (real) Modeled valuation $48M (est)$2.4M$48MSeries A2013Series A · 2014-08-20 Raised $1.0M (real) Modeled valuation $20M (est)$1.0M$20MSeries A2014Series A · 2017-03-13 Raised $4.2M (real) Modeled valuation $84M (est)$4.2M$84MSeries A2017+$7.4M+$2.4M+$1.0M+$4.2MCumulative $25M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$10.2M · 2010
Series A extension$7.4M · 2011
Series A extension$2.4M · 2013
Series A extension$1.0M · 2014
Series A extension$4.2M · 2017

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 33%.

Modeled valuation trajectory
$84.4M
Base estimate est.
$5.4M
Conservative case
$459.1M
Upside case
$19.0M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series A · modeled $204.8M · 2010-06-032010Series A · modeled $150.3M · 2011-09-30Series A · modeled $48.4M · 2013-11-04Series A · modeled $20.2M · 2014-08-20Series A · modeled $84.4M · 2017-03-132017
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
6.0 yr
Elapsed time used
9.3 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
20 mo
Avg between rounds
$3.7M/yr
Capital velocity
16.1 yr
On record since
2010
First round
5
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 10× above median
This company$25.2M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.7× of median
This company$4.2M
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 3.8× above median
This company$84.4M
Sector median$22.1M

Raised more than 87% of sector peers (real $). Modeled value above 76% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #121 of 157.

This companyCohort peer
$10.0M$100.0M$1.0B$10.0M$100.0MCapital raised (log)HemoSonics, LLC · Series A Raised $24.9M · modeled $302.7M (est)Airxpanders Inc · Series A Raised $60.0M · modeled $300.5M (est)Mercator Medsystems Inc · Series A Raised $20.5M · modeled $289.2M (est)Simple Contacts Inc. · Series A Raised $24.1M · modeled $285.5M (est)AVG Holdings, Inc. · Series A Raised $14.0M · modeled $282.5M (est)Avia Holdings, Llc · Series A Raised $27.9M · modeled $272.7M (est)Traditions at Rivertown Park, LLC · Series A Raised $13.5M · modeled $272.4M (est)Access Integrated Healthcare, LLC · Series A Raised $13.2M · modeled $265.8M (est)Gauss Surgical, Inc. · Series A Raised $20.5M · modeled $254.2M (est)4WEB, Inc. · Series A Raised $12.5M · modeled $252.2M (est)Iantech, Inc. · Series A Raised $12.2M · modeled $246.7M (est)AbsoluteCARE, Inc. · Series A Raised $25.7M · modeled $242.6M (est)LoneStar Heart, Inc. (this company) Raised $25.2M · modeled $84.4M (est)LoneStar Heart, Inc.
CompanyStageRaised · realValue · estvs peer med.
HemoSonics, LLCSeries A$24.9M$302.7M2.50×
Airxpanders IncSeries A$60.0M$300.5M2.48×
Mercator Medsystems IncSeries A$20.5M$289.2M2.39×
Simple Contacts Inc.Series A$24.1M$285.5M2.36×
AVG Holdings, Inc.Series A$14.0M$282.5M2.33×
Avia Holdings, LlcSeries A$27.9M$272.7M2.25×
Traditions at Rivertown Park, LLCSeries A$13.5M$272.4M2.25×
Access Integrated Healthcare, LLCSeries A$13.2M$265.8M2.20×
Gauss Surgical, Inc.Series A$20.5M$254.2M2.10×
4WEB, Inc.Series A$12.5M$252.2M2.08×
Iantech, Inc.Series A$12.2M$246.7M2.04×
AbsoluteCARE, Inc.Series A$25.7M$242.6M2.00×
LoneStar Heart, Inc. this companySeries A$25.2M$84.4M0.70×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$10.2M2010-06-03$46.1M$204.8M85%
Series A$7.4M2011-09-30$33.9M$150.3M85%
Series A$2.4M2013-11-04$10.9M$48.4M85%
Series A$1.0M2014-08-20$4.5M$20.2M85%
Series A$4.2M2017-03-13$19.0M$84.4M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$10.2M2010-06-03
    • First recorded raise — entered as Series A.
    • 10 investors on this round.
  2. Series A$7.4M2011-09-30
    • Raised 16 mo later, in step with the ~14 mo sector norm.
    • Round 1.4× smaller than the prior — bridge or down round.
    • 11 investors on this round.
  3. Series A$2.4M2013-11-04
    • Raised again after 25 mo — slower than the ~14 mo sector norm.
    • Round 3.1× smaller than the prior — bridge or down round.
    • Switched to Rule 506(b) (was Rule 06).
    • 3 investors on this round.
  4. Series A$1.0M2014-08-20
    • Raised 9 mo later, in step with the ~14 mo sector norm.
    • Round 2.4× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  5. Series A$4.2M2017-03-13
    • Raised again after 31 mo — slower than the ~14 mo sector norm.
    • Round 4.2× larger than the prior — scaling up.
    • 5 investors on this round.
Intelligence
2018 ~Q4
Modeled next raise · ~20mo cadence
$12.6M
Modeled next size est.range $8.2M$20.1M
4.2×
Last step-up
$3.7M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Olav B. Bergheim12 other2010-06
Hugh B. Neuharth6 other2011-09
CHARLES CHON4 other2017-03
Raymond W. Cohen4 other2011-09
David Nikodem3 other2017-03
Fan Yu3 other2017-03
ANDREW COATS1 other2017-03
Charles Chungsik Chon1 other2014-08
Andrew J. Stewart Coats2013-11
Eric B Olson2010-06
Fan W. Yu2013-11
Frank Ahmann2017-03
Frank B. Ahmann2011-09
Mark B. Maciejewski2011-09
Ray B Cohen2010-06
Shan-Ju Yeh2017-03
Stephan Rietiker2017-03
Registry & provenance

LoneStar Heart, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1493499
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
CardioPolymers, Inc.Other Health CareSeries A$13.6M$273.9Mnetwork2 shared operators · same sector · same stage
Anaxiom CorpOther Health CareSeries A$9.5M$19.7Mnetwork2 shared operators · same sector · same stage
Metronom Health, Inc.HealthtechSeries B$48.6M$476.9Mnetwork3 shared operators
Prelude CorpBiotechnologySeries A$40.9M$13.8Mnetwork2 shared operators · same stage
Sonendo, Inc.Other Health CareSeries C$241.5M$33.0Mnetwork2 shared operators · same sector
Venclose, Inc.Other Health CareSeries B$27.1M$600.3Mnetwork1 shared operator · same sector
Arges Imaging Inc.Other Health CarePre-Seed$855K$26.4Mnetwork2 shared operators · same sector
Empirical Spine, Inc.Other Health CareSeries A$25.3M$95.8Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
HeartBeam, Inc.Other Health CarePre-Seed$6.2M85%
National Cardiac Inc.Other Health CarePre-Seed$17.9M85%
CardioNXT, Inc.Other Health CareSeed$74.4M84%
Ancora Heart, Inc.Other Health CareSeries C$1.4B84%
Prar, Inc.Other Health CarePre-Seed$680K84%
Aqua Heart IncOther Health CareSeries A$4.5M83%
Cardialen, Inc.Other Health CareSeries B$71.9M83%
HeartFlow Holding, Inc.Other Health CareSeries D+$432.6M83%
Frequently asked
How much funding has LoneStar Heart, Inc. raised?
LoneStar Heart, Inc. has raised approximately $25.2M in disclosed capital across 5 recorded financing rounds, aggregated from public filings.
What is LoneStar Heart, Inc.'s estimated valuation?
Provath's modeled valuation for LoneStar Heart, Inc. is approximately $84.4M (modeled range $5.4M–$459.1M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is LoneStar Heart, Inc. at?
LoneStar Heart, Inc.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Mon Mar 13.
What does LoneStar Heart, Inc. do and where is it based?
LoneStar Heart, Inc. operates in the Other Health Care sector, based in IRVINE.
Explore related

See where LoneStar Heart, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at LoneStar Heart, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.